Vesiculopolins, a New Class of Anti-Vesiculoviral Compounds, Inhibit Transcription Initiation of Vesiculoviruses

Vesicular stomatitis virus (VSV) represents a promising platform for developing oncolytic viruses, as well as vaccines against significant human pathogens. To safely control VSV infection in humans, small-molecule drugs that selectively inhibit VSV infection may be needed. Here, using a cell-based h...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogino, Minako, Fedorov, Yuriy, Adams, Drew J., Okada, Kazuma, Ito, Naoto, Sugiyama, Makoto, Ogino, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783830/
https://www.ncbi.nlm.nih.gov/pubmed/31540123
http://dx.doi.org/10.3390/v11090856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783830/
https://www.ncbi.nlm.nih.gov/pubmed/31540123
http://dx.doi.org/10.3390/v11090856

Ejemplares similares